Indiana University

Running trials

• Not yet recruiting

  Pilot of an AI-Enabled Autism Caregiver Support Tool in Indiana and Kenya

  NCT07821619· Source

• Not yet recruiting

  Iron Repletion in Cystic Fibrosis

  NCT07903311· Phase 4· Source

• Recruiting

  Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial

  NCT07746388· Phase 2· Source

• Not yet recruiting

  [18F]-AraG PET Imaging in LA HNSCC

  NCT07168785· Early phase 1· Source

• Recruiting

  App-Based Certified Diabetes Education Therapy (AB-CDE)

  NCT07282639· Source

• Enrolling by invitation

  Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection

  NCT07198945· Source

• Recruiting

  Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  NCT07579702· Source

• Recruiting

  A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

  NCT07143968· Phase 2· Source

• Recruiting

  A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  NCT07061574· Phase 1/2· Source

• Recruiting

  A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

  NCT07306559· Phase 1· Source

• Recruiting

  A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

  NCT07280013· Phase 1· Source

• Recruiting

  INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

  NCT07224321· Phase 2· Source

• Recruiting

  A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  NCT06968845· Phase 2· Source

• Enrolling by invitation

  Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

  NCT07640139· Source

• Active, not recruiting

  A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  NCT07107945· Phase 3· Source

• Recruiting

  SPARK Healthy Sleep

  NCT07119268· Source

• Recruiting

  Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  NCT07175428· Phase 2· Source

• Active, not recruiting

  PSMA PET Combined With MRI for the Detection of PCa

  NCT07052214· Phase 3· Source

• Active, not recruiting

  A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

  NCT07047118· Phase 2· Source

• Recruiting

  Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

  NCT06935591· Source

• Recruiting

  Denosumab for Type 1 Diabetes

  NCT06524960· Phase 1/2· Source

• Active, not recruiting

  T1D Pregnancy & Me

  NCT06959316· Source

• Recruiting

  Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  NCT06819007· Phase 3· Source

• Recruiting

  Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  NCT06780670· Phase 2/3· Source

• Recruiting

  A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

  NCT06541847· Phase 2· Source

• Recruiting

  A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

  NCT06562543· Phase 4· Source

• Active, not recruiting

  Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

  NCT06691984· Phase 3· Source

• Recruiting

  Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

  NCT06401577· Source

• Recruiting

  A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

  NCT06545955· Phase 3· Source

• Recruiting

  Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

  NCT06423430· Source

• Active, not recruiting

  Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

  NCT06484114· Source

• Enrolling by invitation

  Large-Scale Implementation of a Decision Aid About Colorectal Cancer Screening

  NCT06597955· Source

• Active, not recruiting

  PREVENT ALL ALS Study

  NCT06581861· Source

• Recruiting

  ASSESS ALL ALS Study

  NCT06578195· Source

• Recruiting

  Acoustic Waveform Respiratory Evaluation

  NCT06512064· Source

• Recruiting

  Fibrosis Lessens After Metabolic Surgery

  NCT06374875· Phase 4· Source

• Active, not recruiting

  A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

  NCT06388733· Phase 3· Source

• Active, not recruiting

  A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

  NCT06360354· Phase 1· Source

• Recruiting

  Health Outcomes of Parents With Cystic Fibrosis-Aim 2

  NCT06296394· Source

• Active, not recruiting

  P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

  NCT06014762· Phase 1· Source

• Recruiting

  Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study

  NCT05573490· Source

• Recruiting

  National Liver Cancer Screening Trial

  NCT06084234· Phase 4· Source

• Recruiting

  uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  NCT05874921· Source

• Active, not recruiting

  Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

  NCT05743244· Phase 2· Source

• Recruiting

  Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up

  NCT06106646· Source

• Enrolling by invitation

  Alzheimer's Plasma Extension

  NCT06416072· Source

• Recruiting

  Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  NCT05797831· Phase 2/3· Source

• Active, not recruiting

  A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

  NCT05531656· Phase 2· Source

• Enrolling by invitation

  Alzheimer's Disease Neuroimaging Initiative 4

  NCT05617014· Source

• Recruiting

  SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  NCT05303519· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes7 recruiting
• Alzheimer disease5 recruiting
• Type 2 diabetes4 recruiting
• Asthma3 recruiting
• Cystic fibrosis3 recruiting
• Heart failure3 recruiting
• Obesity3 recruiting
• Stroke3 recruiting
• ALS (motor neurone disease)2 recruiting
• Atrial fibrillation2 recruiting
• Bladder cancer2 recruiting
• Colorectal cancer2 recruiting
• Coronary artery disease2 recruiting
• Endometrial cancer2 recruiting
• Fatty liver disease (MASLD/MASH)2 recruiting
• Frontotemporal dementia2 recruiting
• Multiple myeloma2 recruiting
• Ovarian cancer2 recruiting
• Prostate cancer2 recruiting
• Autism1 recruiting
• Childhood cancers1 recruiting
• COPD1 recruiting
• Depression1 recruiting
• Glioblastoma1 recruiting
• Head and neck cancer1 recruiting
• Hepatitis B1 recruiting
• High blood pressure1 recruiting
• HIV1 recruiting
• Huntington's disease1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Parkinson disease1 recruiting
• Schizophrenia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Ultrasound Acute Chest Syndrome Sickle Cell Disease

  NCT06880679· Source

• Withdrawn

  Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy

  NCT04192929· Source

• Terminated

  Developing a Childhood Asthma Risk Passive Digital Marker

  NCT05826561· Source

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  NCT06372964· Phase 3· Source

• Completed

  A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

  NCT06309992· Phase 3· Source

• Terminated

  Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

  NCT05712694· Phase 3· Source

• Recruiting

  A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  NCT06084936· Phase 3· Source

• Recruiting

  DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

  NCT05882058· Phase 2· Source

• Completed

  Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

  NCT05783297· Source

• Completed

  Telemedicine for Children With Sickle Cell Disease

  NCT05087303· Source

• Completed

  Abbott i-STAT High Sensitivity Troponin I Study

  NCT05629572· Source

• Completed

  Digital Detection of Dementia (D Cubed) Studies: D2

  NCT05231954· Phase 4· Source

• Completed

  A Study of JNJ-55308942 in the Treatment of Bipolar Depression

  NCT05328297· Phase 2· Source

• Completed

  FT576 in Subjects With Multiple Myeloma

  NCT05182073· Phase 1· Source

• Completed

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· Phase 3· Source

• Completed

  Afrezza® INHALE-1 Study in Pediatrics

  NCT04974528· Phase 3· Source

• Completed

  A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

  NCT05033080· Phase 3· Source

• Completed

  Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers

  NCT04948866· Source

• Completed

  A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

  NCT04809363· Phase 4· Source

• Completed

  Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

  NCT06177691· Source

• Terminated

  A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)

  NCT04776018· Phase 1/2· Source

• Terminated

  A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

  NCT04844073· Phase 1/2· Source

• Completed

  Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

  NCT04300920· Phase 3· Source

• Completed

  A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

  NCT04640077· Phase 2· Source

• Completed

  Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy

  NCT06748040· Source

• Completed

  Genetic Testing to Understand and Address Renal Disease Disparities Across the United States

  NCT04191824· Source

• Terminated

  A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

  NCT04271475· Phase 3· Source

• Completed

  Advancing Understanding of Transportation Options

  NCT04141891· Source

• Completed

  Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease

  NCT04121858· Source

• Completed

  Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

  NCT03904134· Source

• Completed

  TRC-PAD Program: In-Clinic Trial-Ready Cohort

  NCT04004767· Source

• Completed

  Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

  NCT03709680· Phase 2· Source

• Completed

  Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

  NCT03656926· Phase 3· Source

• Completed

  HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients

  NCT03734393· Source

• Completed

  Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

  NCT03678753· Phase 3· Source

• Completed

  Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

  NCT03258931· Phase 3· Source

• Completed

  HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

  NCT03500315· Source

• Completed

  STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

  NCT03489629· Phase 2· Source

• Completed

  Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas

  NCT03231306· Phase 2· Source

• Completed

  Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

  NCT03269994· Phase 3· Source

• Completed

  Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)

  NCT03285321· Phase 2· Source

• Completed

  Vitamin C Supplementation to Pregnant Smokers: Follow-up of 2 Randomized Trials Plus Changes in DNA Methylation

  NCT03206710· Source

• Completed

  VCSIP Follow-up Study

  NCT03203603· Source

• Completed

  Alzheimer's Disease Neuroimaging Initiative 3

  NCT02854033· Source

• Completed

  Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

  NCT02844465· Source

• Completed

  Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

  NCT02360579· Phase 2· Source

• Completed

  RNS® System Epilepsy Post-Approval Study

  NCT02403843· Source